Katabi Maha 4
4 · RayzeBio, Inc. · Filed Sep 21, 2023
Insider Transaction Report
Form 4
RayzeBio, Inc.RYZB
Katabi Maha
Director
Transactions
- Conversion
Common Stock
2023-09-19+973,653→ 973,653 total(indirect: See footnote) - Purchase
Common Stock
2023-09-19$18.00/sh+236,111$4,249,998→ 1,209,764 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2023-09-19−973,653→ 0 total(indirect: By Sofinnova Venture Partners X, L.P.)→ Common Stock (973,653 underlying) - Conversion
Common Stock
2023-09-19+973,653→ 973,653 total(indirect: See footnote) - Purchase
Common Stock
2023-09-19$18.00/sh+236,111$4,249,998→ 1,209,764 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2023-09-19−973,653→ 0 total(indirect: By Sofinnova Venture Partners XI, L.P.)→ Common Stock (973,653 underlying)
Footnotes (4)
- [F1]Every 5.141 shares of Series D Convertible Preferred Stock (the "Preferred Stock") automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
- [F2]The shares are held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.P. ("SM X LP"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over these shares, and Sofinnova Management X-A, L.L.C. ("SM X LLC"), the general partner of SM X LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM X LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
- [F3]The shares are held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP"), the general partner of SVP XI, may be deemed to have sole voting and dispositive power over these shares, and Sofinnova Management XI, L.L.C. ("SM XI LLC"), the general partner of SM XI LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM XI LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
- [F4]The shares were purchased in the Issuer's initial public offering.